These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1835868)

  • 21. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.
    Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R
    Am J Med; 1990 Jun; 88(6):619-24. PubMed ID: 2189305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T
    Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with AIDS-related tumors and chemotherapy-induced bone-marrow suppression.
    Tirelli U; Sorio R; Monfardini S; Lazzarin A; Rossi G; Mazzanti P
    J Acquir Immune Defic Syndr (1988); 1990; 3(11):1115. PubMed ID: 2213514
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical use of hematopoietic growth factors].
    Robak T
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
    [No Abstract]   [Full Text] [Related]  

  • 26. Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application.
    Neumanaitis J
    Transfusion; 1993 Jan; 33(1):70-83. PubMed ID: 8424270
    [No Abstract]   [Full Text] [Related]  

  • 27. Indications and guidelines for the use of hematopoietic growth factors.
    Goodnough LT; Anderson KC; Kurtz S; Lane TA; Pisciotto PT; Sayers MH; Silberstein LE
    Transfusion; 1993; 33(11):944-59. PubMed ID: 7505068
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.
    Takahashi M; Yoshida Y; Kaku K; Masaoka T; Moriyama Y; Nakanishi S; Kaneko T; Shibata A; Miwa S
    Acta Haematol; 1993; 89(4):189-94. PubMed ID: 8212999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic colony-stimulating factors. Uses in combination with standard chemotherapeutic regimens and in support of dose intensification.
    Neidhart JA
    Cancer; 1992 Aug; 70(4 Suppl):913-20. PubMed ID: 1379115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
    AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
    Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
    Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
    Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases.
    Rose C; Wattel E; Bastion Y; Berger E; Bauters F; Coiffier B; Fenaux P
    Leukemia; 1994 Sep; 8(9):1458-62. PubMed ID: 8090025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
    Hewitt RG; Morse GD
    Pharmacotherapy; 1992; 12(6):455-61. PubMed ID: 1492010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte-macrophage colony stimulating factor (GM-CSF) as an adjunct to autologous bone marrow transplantation (ABMT) in hematology. Results of the interim analysis of the Schering-Plough/Sandoz International trial and considerations on increased safety in the transplant ward.
    Gorin NC; Fouillard L
    Pathol Biol (Paris); 1992 Nov; 39(9):954-5. PubMed ID: 1538950
    [No Abstract]   [Full Text] [Related]  

  • 40. Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Hess U; Ganser A; Schnürch HG; Seipelt G; Ottmann OG; Falk S; Schulz G; Hoelzer D
    Br J Haematol; 1992 Feb; 80(2):254-6. PubMed ID: 1550786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.